<DOC>
	<DOCNO>NCT02498769</DOCNO>
	<brief_summary>In study , investigator aim determine whether inject botulinum toxin epicardial fat pad efficacious safe decrease postoperative atrial fibrillation ( POAF ) cardiac surgery . The investigator test hypothesis botulinum toxin inject epicardial fat pad reduce POAF length stay ( LOS ) without increase adverse event . This prospective randomize trial 130 patient undergoing coronary artery bypass graft ( CABG ) , valve surgery CABG + valve surgery cardiopulmonary bypass . Patients randomize receive either botulinum toxin ( 50 unit per fat pad , n=65 ) normal saline/placebo ( 1 mL per fat pad , n=65 ) inject epicardial fat pad . All patient receive standardize anesthetic , surgical , post-surgical care . The primary outcome study time occurrence in-hospital POAF . Based previous work pilot trial show pronounced reduction ( relative risk reduction 77 % ) POAF inject botulinum epicardial fat pad , investigator anticipate significant reduction risk POAF epicardial botulinum cohort , include valve surgery patient .</brief_summary>
	<brief_title>Temporary Autonomic Blockade Prevent Atrial Fibrillation After Cardiac Surgery</brief_title>
	<detailed_description>Purpose study : A pilot study determine whether inject botulinum toxin epicardial fat pad efficacious safe decrease postoperative atrial fibrillation ( POAF ) cardiac surgery Hypothesis test : Botulinum toxin inject epicardial fat pad reduces POAF . Design Procedures : This prospective randomized pilot trial 130 patient undergoing coronary artery bypass graft ( CABG ) , valve surgery CABG + valve surgery via median sternotomy cardiopulmonary bypass . Patients &lt; 50 year age , chronic atrial fibrillation , prior cardiac surgery , EF &lt; 25 % , preoperative inotropic support , hepatic renal failure , know sensitivity botulinum toxin , debilitate neuromuscular disease , history atrioventricular block exclude study . Prior surgery , patient baseline Mini-Mental State Examination ( MMSE ) blood sample indwell arterial line venipuncture measurement inflammatory genomic marker . Half patient randomize receive injection epicardial botulinum toxin addition standard care , describe . The half receive epicardial injection normal saline . Institution cardiopulmonary bypass perform accord routine surgical protocol . After institute CPB , botulinum toxin ( normal saline ) injection perform surgeon . This dose select give prior report effectiveness prevent POAF cardiac surgery small pilot study . ( Pokushalov et al. , 2014 ) After completion surgery separation CPB , patient proceed along institutional Cardiac Surgical Caremap . All patient monitor continuous ECG ( telemetry ) hospital discharge . POAF diagnose telemetry 12-lead ECG , define new-onset occurs postoperatively time hospital discharge . POAF , occur , treat per routine care . POAF define detectable atrial fibrillation discharge last &gt; 30 second . On postoperative day ( POD ) 4 , member study team visit patient administer MMSE capture 5-minute ECG Holter monitor . In addition , patient contact monthly 4 month one year surgery follow , medical record review evidence readmission , arrhythmia , adverse event .</detailed_description>
	<mesh_term>Atrial Fibrillation</mesh_term>
	<mesh_term>Botulinum Toxins , Type A</mesh_term>
	<mesh_term>incobotulinumtoxinA</mesh_term>
	<mesh_term>abobotulinumtoxinA</mesh_term>
	<mesh_term>onabotulinumtoxinA</mesh_term>
	<mesh_term>Botulinum Toxins</mesh_term>
	<criteria>Undergoing cardiac surgery cardiopulmonary bypass via median sternotomy coronary artery bypass graft ( CABG ) valve surgery CABG + valve surgery &lt; 50years age &gt; 90years age chronic AF AF time screen preoperative heart block ( first degree great ) LVEF &lt; 25 % renal failure hepatic failure know sensitivity Botulinum toxin debilitate neuromuscular disease preoperative need inotropes/vasopressors intraaortic balloon pump plan MAZE procedure history catheter ablation AF use VaughnWilliams class I III drug within 5 elimination half life ( within 2 month amiodarone ) undergo minimallyinvasive cardiac surgery prior cardiac surgery</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Cardiac Surgery</keyword>
	<keyword>Postoperative Complications</keyword>
	<keyword>Autonomic Nerve Block</keyword>
</DOC>